Journal of Pain Management and Therapy

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Journal of Pain Management and Therapy 44 7897 074717

Mini Review - Journal of Pain Management and Therapy (2025) Volume 9, Issue 3

Evolving pain management: Biopsychosocial and personalized.

Ryuji S. Nakamura*

Department of Pain Medicine, University of Tokyo, Japan

*Corresponding Author:
Ryuji S. Nakamura
Department of Pain Medicine
University of Tokyo, Japan.
E-mail: ryuji.nakamura@tokyopainresearch.jp

Received : 01-May-2025, Manuscript No. AAPMT-25-264; Editor assigned : 05-May-2025, PreQC No. AAPMT-25-264(PQ); Reviewed : 23-May-2025, QC No AAPMT-25-264; Revised : 03-Jun-2025, Manuscript No. AAPMT-25-264(R); Published : 12-Jun-2025 , DOI : 10.35841/aapmt-9.3.264

Citation: Nakamura RS. Evolving pain management: Biopsychosocial and personalized. J Pain Manage Ther. 2025;09(03):264.

Visit for more related articles at Journal of Pain Management and Therapy

Introduction

Pain neuroscience education (PNE) is crucial for managing musculoskeletal pain. It helps patients understand pain from a biopsychosocial perspective, moving beyond just the biomedical model. This shift in understanding empowers individuals, reduces pain-related fear, and ultimately improves functional outcomes. Integrating PNE into comprehensive treatment plans is strongly supported by evidence, demonstrating its effectiveness in altering pain beliefs and behaviors for better long-term management [1].

Implementing opioid-sparing strategies during total knee arthroplasty significantly reduces postoperative opioid consumption while maintaining effective pain control. These multimodal approaches, which often combine regional anesthesia with non-opioid medications, are vital for minimizing opioid-related side effects and mitigating the risk of long-term dependence. This approach contributes to improved patient recovery trajectories and overall outcomes [2].

Identifying key risk factors for chronic post-surgical pain is essential for proactive intervention. Pre-existing chronic pain, higher preoperative pain intensity, and psychological distress like anxiety or depression are strong predictors. Recognizing these factors allows clinicians to develop targeted strategies, such as enhanced psychological support or individualized analgesic regimens, aiming to prevent the persistent pain transition after surgery [3].

Pain genetics is a rapidly evolving frontier, offering insights into individual variations in pain perception and susceptibility, particularly for conditions like neuropathic pain. Understanding the genetic underpinnings of pain pathways is paving the way for personalized pain medicine. This approach promises more effective and tailored therapeutic strategies, moving beyond broad treatments to those specifically suited to a patient's genetic profile [4].

Central sensitization is a hallmark mechanism in chronic pain states, particularly chronic low back pain, characterized by heightened nervous system sensitivity. Utilizing tools such as the Central Sensitization Inventory (CSI) and Quantitative Sensory Testing (QST) is critical for accurate diagnosis and differential assessment of this phenomenon. These assessments help in tailoring treatment strategies that directly address the underlying pain mechanisms, rather than just the symptoms [5].

Non-pharmacological interventions are increasingly important for managing chronic pain, offering effective alternatives or adjuncts to medication. A systematic review confirms their value, encompassing approaches like physical therapy, exercise, and cognitive-behavioral therapy. These methods are shown to reduce pain intensity and improve functional capacity, underscoring the benefits of a comprehensive, multidisciplinary strategy for chronic pain relief [6].

Enhanced Recovery After Surgery (ERAS) protocols significantly optimize post-surgical pain management and accelerate overall recovery across various surgical specialties, including spine surgery. These comprehensive pathways integrate best practices from preoperative counseling through postoperative rehabilitation, leading to reduced opioid consumption, shorter hospital stays, and fewer complications. Standardized implementation of ERAS is vital to maximize its widespread benefits [7].

Advances in pain genetics are transforming the landscape of pain management, moving from identifying underlying mechanisms to enabling precision medicine. Understanding how genetic variations influence pain perception, response to analgesics, and chronic pain risk allows for more accurate prognoses and highly individualized treatment plans. This targeted approach is poised to improve therapeutic outcomes and minimize adverse drug reactions [8].

Fear-avoidance models remain critical for understanding chronic pain, emphasizing how fear of pain drives avoidance behaviors that can perpetuate disability. However, these models need updating to integrate a broader range of biopsychosocial factors, including patient resilience, self-efficacy, and social context. Evolving these frameworks will lead to more nuanced and comprehensive approaches to chronic pain assessment and management [9].

Cannabinoids modulate pain through intricate neuropharmacological mechanisms, primarily interacting with the endocannabinoid system (ECS). This system regulates neurotransmission, inflammation, and pain perception across central and peripheral nervous systems. Ongoing research into cannabinoids is revealing their significant potential as novel therapeutic agents for various pain conditions, prompting further studies into optimal dosing and long-term safety profiles [10].

 

Conclusion

Pain neuroscience education (PNE) is crucial for managing musculoskeletal pain, promoting a biopsychosocial understanding that reduces fear and improves outcomes. Opioid-sparing strategies, particularly in total knee arthroplasty, successfully reduce postoperative opioid consumption and related side effects through multimodal approaches. Identifying risk factors like pre-existing pain and psychological distress is vital for preventing chronic post-surgical pain with targeted interventions. Research into pain genetics is advancing personalized pain medicine by uncovering genetic variations that influence pain perception and treatment response, especially for conditions like neuropathic pain. Central sensitization, a key mechanism in chronic pain, requires specific diagnostic tools like the Central Sensitization Inventory (CSI) and Quantitative Sensory Testing (QST) for tailored treatment. Non-pharmacological interventions, including physical therapy, exercise, and cognitive-behavioral therapy, offer effective pain reduction and functional improvement in chronic pain management. Enhanced Recovery After Surgery (ERAS) protocols significantly optimize post-surgical pain management and recovery, reducing opioid use and hospital stays across specialties. Fear-avoidance models, while crucial for understanding chronic pain, need to evolve to incorporate broader biopsychosocial factors like resilience and self-efficacy for more comprehensive management. Finally, cannabinoids are showing significant potential as novel therapeutic agents for pain by modulating the endocannabinoid system (ECS), necessitating further research into their optimal use and safety.

References

References

    1. Jo N, Antoon JW, Lieven DB. The role of pain neuroscience education in musculoskeletal pain: An evidence-based and expert-driven perspective on the clinical applicability. Pain Rep. 2023;8(2):e1078.

Indexed at, Google Scholar, Crossref

    1. Shu-Ching C, Ken-Ching C, Yao-Hung L. Opioid-sparing strategies and outcomes in patients undergoing total knee arthroplasty: a systematic review and meta-analysis. Ann Palliat Med. 2023;12(4):681-697.

Indexed at, Google Scholar, Crossref

    1. Hans JG, Esther MP, Erik KA. Risk factors for chronic post-surgical pain: A systematic review and meta-analysis. Pain. 2023;164(7):1443-1457.

Indexed at, Google Scholar, Crossref

    1. David LB, Ioana B, Michael C. Pain genetics: a new frontier for pain medicine. Pain. 2019;160(Suppl 1):S1-S12.

Indexed at, Google Scholar, Crossref

    1. Ronggang Y, Jaehyun K, Young-Sung K. Central sensitization inventory and quantitative sensory testing in the differential diagnosis of chronic low back pain. Sci Rep. 2023;13(1):18991.

Indexed at, Google Scholar, Crossref

    1. Ana C, Pablo dlI, María AG. Effectiveness of Non-Pharmacological Interventions in the Treatment of Chronic Pain: A Systematic Review. J Clin Med. 2023;12(17):5525.

Indexed at, Google Scholar, Crossref

    1. Jacob M, Rachel R, Dale T. Current state of enhanced recovery after surgery in spine: a systematic review and expert consensus. Spine J. 2023;23(9):1420-1433.

Indexed at, Google Scholar, Crossref

    1. Junhua M, Zhenwei L, Dandan Y. Advances in pain genetics: from mechanisms to precision medicine. J Transl Med. 2023;21(1):798.

Indexed at, Google Scholar, Crossref

    1. David S, Thomas P, Rob JSS. Fear-avoidance models in chronic pain: Time for an update. Pain. 2023;164(3):477-483.

Indexed at, Google Scholar, Crossref

    1. Arman K, Reza G, Hadi A. Cannabinoids and pain: A review of the neuropharmacological mechanisms. J Cannabis Res. 2023;5(1):31.

Indexed at, Google Scholar, Crossref

Get the App